JP2010500003A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500003A5
JP2010500003A5 JP2009504513A JP2009504513A JP2010500003A5 JP 2010500003 A5 JP2010500003 A5 JP 2010500003A5 JP 2009504513 A JP2009504513 A JP 2009504513A JP 2009504513 A JP2009504513 A JP 2009504513A JP 2010500003 A5 JP2010500003 A5 JP 2010500003A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
acid sequence
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009504513A
Other languages
English (en)
Japanese (ja)
Other versions
JP5339291B2 (ja
JP2010500003A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/065992 external-priority patent/WO2008018642A2/en
Publication of JP2010500003A publication Critical patent/JP2010500003A/ja
Publication of JP2010500003A5 publication Critical patent/JP2010500003A5/ja
Application granted granted Critical
Publication of JP5339291B2 publication Critical patent/JP5339291B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009504513A 2006-08-10 2007-08-10 乳癌に関連する遺伝子およびポリペプチド Expired - Fee Related JP5339291B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US83742806P 2006-08-10 2006-08-10
US60/837,428 2006-08-10
US84025006P 2006-08-25 2006-08-25
US60/840,250 2006-08-25
US91502207P 2007-04-30 2007-04-30
US60/915,022 2007-04-30
PCT/JP2007/065992 WO2008018642A2 (en) 2006-08-10 2007-08-10 Genes and polypeptides relating to breast cancers

Publications (3)

Publication Number Publication Date
JP2010500003A JP2010500003A (ja) 2010-01-07
JP2010500003A5 true JP2010500003A5 (enExample) 2010-09-24
JP5339291B2 JP5339291B2 (ja) 2013-11-13

Family

ID=38627000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504513A Expired - Fee Related JP5339291B2 (ja) 2006-08-10 2007-08-10 乳癌に関連する遺伝子およびポリペプチド

Country Status (8)

Country Link
US (2) US8673548B2 (enExample)
EP (1) EP2057187B1 (enExample)
JP (1) JP5339291B2 (enExample)
KR (1) KR20090064378A (enExample)
BR (1) BRPI0716498A2 (enExample)
CA (1) CA2660438A1 (enExample)
SG (1) SG174071A1 (enExample)
WO (1) WO2008018642A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1898563B (zh) 2003-09-24 2011-11-23 肿瘤疗法科学股份有限公司 诊断乳腺癌的方法
RU2421462C2 (ru) 2005-07-29 2011-06-20 Таргитид Гроус, Инк. Защитное действие доминантно-негативного мутантного белка krp от ингибирования активного комплекса циклин-cdk krp дикого типа
JP5514453B2 (ja) * 2008-03-04 2014-06-04 株式会社キノファーマ 発光タンパク質を用いたリン酸化酵素阻害物質のスクリーニング方法
EP2275567A1 (en) * 2009-07-15 2011-01-19 Rheinische Friedrich-Wilhelms-Universität Bonn Nucleic acid expression construct and its use as a cell proliferation marker
CN102781316B (zh) * 2010-03-01 2016-07-06 陶制药有限责任公司 癌症诊断和成像
EP2638167A4 (en) * 2010-11-12 2014-03-26 Targeted Growth Inc DOMINANT NEGATIVE MUTANT KIP PROTEINS IN ZEA-MAIZE AND METHOD FOR THEIR USE
EP2697378A4 (en) 2011-04-11 2014-10-01 Targeted Growth Inc IDENTIFICATION AND USE OF KRP MUTANTS IN PLANTS
WO2012142116A2 (en) 2011-04-11 2012-10-18 Targeted Growth, Inc. Identification and use of krp mutants in wheat
DK2738255T3 (en) * 2011-07-29 2017-03-06 Univ Tokushima ERAP1-Derived Peptide and its Use
RU2633503C2 (ru) * 2011-10-28 2017-10-12 Онкотерапи Сайенс, Инк. Пептиды торк и содержащие их вакцины
CN104126010B (zh) 2011-12-16 2021-04-06 国立大学法人东京医科齿科大学 嵌合的双链核酸
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer
WO2016011143A1 (en) * 2014-07-15 2016-01-21 Temple University Of The Commonwealth System Of Higher Education Stabilized peptide fragments from redoxin proteins as cancer biomarkers
CN104497147B (zh) * 2014-12-23 2018-07-03 四川大学 一种双受体识别的串联型穿膜肽修饰的肿瘤靶向纳米递药系统
JP6923135B2 (ja) 2016-01-19 2021-08-18 国立大学法人徳島大学 がん治療用ペプチド及びそれを含む医薬組成物
EP3405579A1 (en) 2016-01-22 2018-11-28 Modernatx, Inc. Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
CN111148752B (zh) 2017-07-19 2024-01-16 国立大学法人德岛大学 肽衍生物和包含其的药物组合物
JP7525855B2 (ja) 2018-11-30 2024-07-31 国立大学法人徳島大学 Ｂｉｇ３－ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬
CN114773480A (zh) * 2022-06-07 2022-07-22 厦门大学附属翔安医院 一种抗topk第32位丝氨酸残基磷酸化的抗体
CN116082447A (zh) * 2022-09-09 2023-05-09 湖南大学 一种多肽及其制备方法
CN117757789A (zh) * 2022-09-26 2024-03-26 领星生物科技（上海）有限公司 用于抑制肿瘤生长的siRNA及其应用
CN120944846A (zh) * 2025-10-15 2025-11-14 北京索莱宝科技有限公司 人PP1α蛋白及其Thr320位点磷酸化蛋白的抗原肽及其抗体的制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656698B1 (en) * 1999-06-30 2003-12-02 Millennium Pharmaceuticals, Inc. 12832, a novel human kinase-like molecule and uses thereof
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001296448A1 (en) * 2000-10-03 2002-04-15 Curagen Corporation Tumor marker and methods of use
US7229960B2 (en) * 2000-11-03 2007-06-12 University Of Vermont And State Agricultural College Methods and compositions for inhibiting GRB7
EP1661986A1 (en) * 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
US20030099974A1 (en) * 2001-07-18 2003-05-29 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
WO2003043568A2 (en) 2001-11-15 2003-05-30 The Regents Of The University Of California Compositions and methods for the suppression of mammary epithelial cell proliferation
US20060241015A1 (en) * 2002-01-25 2006-10-26 Zairen Sun Cancer genes
US6833247B2 (en) * 2002-05-14 2004-12-21 Origene Technologies, Inc. Regulated prostate cancer genes
US20030235533A1 (en) * 2002-02-19 2003-12-25 Idec Pharmaceuticals Corporation Prostate specific genes and the use thereof in design or therapeutics
KR20050048615A (ko) 2002-08-19 2005-05-24 제넨테크, 인크. 종양의 진단 및 치료를 위한 조성물 및 방법
CN1703522A (zh) 2002-09-30 2005-11-30 肿瘤疗法科学股份有限公司 诊断睾丸精原细胞瘤的方法
US6971476B2 (en) * 2003-09-05 2005-12-06 D B Industries, Inc. Safety harness
CN1898563B (zh) 2003-09-24 2011-11-23 肿瘤疗法科学股份有限公司 诊断乳腺癌的方法
US7998695B2 (en) * 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
WO2006110593A2 (en) * 2005-04-07 2006-10-19 Macrogenics, Inc. Biological targets for the diagnosis, treatment and prevention of cancer
EP1907582B1 (en) * 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
EP1907580A2 (en) 2005-07-28 2008-04-09 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
BRPI0818533B8 (pt) * 2007-10-11 2021-05-25 Astrazeneca Ab composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
CN102271514A (zh) * 2008-10-30 2011-12-07 肿瘤疗法科学股份有限公司 7-羟基-苯并咪唑-4-基-甲酮衍生物以及包含其的pbk抑制剂

Similar Documents

Publication Publication Date Title
Lu et al. A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway
JP4060886B2 (ja) Ｓｈ３結合ペプチドの単離および利用
KR101653774B1 (ko) 올리고펩타이드 화합물 및 이의 용도
RU2010111120A (ru) Eb13, dlx5, nptx1 и cdkn3 в качестве генов-мишеней для терапии и диагностики рака легкого
Liu et al. FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability
Jeong et al. Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis
EP1105474A2 (en) Human genes and gene expression products v
JPWO2013018690A1 (ja) Ｅｒａｐ１由来ペプチド及びその使用
JP2010512730A5 (enExample)
JP2012501165A5 (enExample)
JP2010512730A (ja) 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ
Chen et al. Direct interaction of 14-3-3ζ with ezrin promotes cell migration by regulating the formation of membrane ruffle
Moreno et al. Distinctive interactomes of RNA polymerase II phosphorylation during different stages of transcription
Qu et al. The nuclear localization of SET mediated by impα3/impβ attenuates its cytosolic toxicity in neurons
JP2010523081A5 (enExample)
CN108289924A (zh) 阻断组蛋白识别结构域的小分子
US8604163B2 (en) EEF2K assays for identifying compounds that inhibit EEF2K activity
Mandel-Gutfreund et al. ARTS, the unusual septin: structural and functional aspects
Reimer et al. Phosphorylation of the N-terminal domain regulates subcellular localization and DNA binding properties of the peptidyl-prolyl cis/trans isomerase hPar14
Zimmerman et al. Finding Plk3
US20060141529A1 (en) Compositions, kits and assays containing reagents directed to cortactin and an ARG/ABL protein kinase
CN101050473B (zh) 抗细胞增殖或抗肿瘤药物的筛选试剂盒、筛选方法及用途
JP2017086027A (ja) 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害
RU2011111532A (ru) Твс1d7 в качестве опухолевого маркера и терапевтической мишени в случае злокачественной опухоли
US8088574B2 (en) Poly(A) polymerase